JP2002524393A5 - - Google Patents

Download PDF

Info

Publication number
JP2002524393A5
JP2002524393A5 JP2000563294A JP2000563294A JP2002524393A5 JP 2002524393 A5 JP2002524393 A5 JP 2002524393A5 JP 2000563294 A JP2000563294 A JP 2000563294A JP 2000563294 A JP2000563294 A JP 2000563294A JP 2002524393 A5 JP2002524393 A5 JP 2002524393A5
Authority
JP
Japan
Prior art keywords
seq
composition
condition
peptide antagonist
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000563294A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002524393A (ja
JP4822585B2 (ja
Filing date
Publication date
Priority claimed from US09/127,815 external-priority patent/US6458925B1/en
Application filed filed Critical
Publication of JP2002524393A publication Critical patent/JP2002524393A/ja
Publication of JP2002524393A5 publication Critical patent/JP2002524393A5/ja
Application granted granted Critical
Publication of JP4822585B2 publication Critical patent/JP4822585B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000563294A 1998-08-03 1999-07-28 ゾヌリンのペプチドアンタゴニストおよびその使用方法 Expired - Lifetime JP4822585B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/127,815 US6458925B1 (en) 1998-08-03 1998-08-03 Peptide antagonists of zonulin and methods for use of the same
US09/127,815 1998-08-03
PCT/US1999/016683 WO2000007609A1 (en) 1998-08-03 1999-07-28 Peptide antagonists of zonulin and methods for use of the same

Publications (3)

Publication Number Publication Date
JP2002524393A JP2002524393A (ja) 2002-08-06
JP2002524393A5 true JP2002524393A5 (enExample) 2006-09-14
JP4822585B2 JP4822585B2 (ja) 2011-11-24

Family

ID=22432094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000563294A Expired - Lifetime JP4822585B2 (ja) 1998-08-03 1999-07-28 ゾヌリンのペプチドアンタゴニストおよびその使用方法

Country Status (18)

Country Link
US (10) US6458925B1 (enExample)
EP (2) EP1698345B1 (enExample)
JP (1) JP4822585B2 (enExample)
KR (1) KR100610389B1 (enExample)
CN (2) CN100348266C (enExample)
AT (2) ATE329606T1 (enExample)
AU (1) AU745507B2 (enExample)
CA (1) CA2338005C (enExample)
DE (2) DE69942753D1 (enExample)
DK (1) DK1102596T3 (enExample)
ES (1) ES2267282T3 (enExample)
HU (1) HU228079B1 (enExample)
IL (2) IL141082A0 (enExample)
NO (1) NO326552B1 (enExample)
NZ (1) NZ509579A (enExample)
RU (1) RU2214267C2 (enExample)
WO (1) WO2000007609A1 (enExample)
ZA (1) ZA200100829B (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
JP2003534287A (ja) * 2000-05-19 2003-11-18 ユニバーシティ・オブ・メリーランド, ボルティモア 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法
FR2844201A1 (fr) * 2002-09-06 2004-03-12 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
WO2003077893A2 (fr) * 2002-03-15 2003-09-25 Rytek Compositions pour le traitement de pathologies fonctionnelles digestives
CA2531491A1 (en) * 2003-07-15 2005-02-03 University Of Maryland, Baltimore Agonist polypeptide of receptor for zot and zonulin
US7125781B2 (en) * 2003-09-04 2006-10-24 Micron Technology, Inc. Methods of forming capacitor devices
US7067385B2 (en) * 2003-09-04 2006-06-27 Micron Technology, Inc. Support for vertically oriented capacitors during the formation of a semiconductor device
US20080038843A1 (en) * 2006-08-11 2008-02-14 University Of Maryland - Baltimore Method of diagnosing celiac disease
US7387939B2 (en) * 2004-07-19 2008-06-17 Micron Technology, Inc. Methods of forming semiconductor structures and capacitor devices
US7439152B2 (en) * 2004-08-27 2008-10-21 Micron Technology, Inc. Methods of forming a plurality of capacitors
US7202127B2 (en) * 2004-08-27 2007-04-10 Micron Technology, Inc. Methods of forming a plurality of capacitors
US20060046055A1 (en) 2004-08-30 2006-03-02 Nan Ya Plastics Corporation Superfine fiber containing grey dope dyed component and the fabric made of the same
US7547945B2 (en) 2004-09-01 2009-06-16 Micron Technology, Inc. Transistor devices, transistor structures and semiconductor constructions
US7320911B2 (en) 2004-12-06 2008-01-22 Micron Technology, Inc. Methods of forming pluralities of capacitors
FR2879100B1 (fr) 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
TW200637573A (en) * 2005-01-14 2006-11-01 Univ Maryland Peptide for delivery of mucosal vaccines
US7557015B2 (en) * 2005-03-18 2009-07-07 Micron Technology, Inc. Methods of forming pluralities of capacitors
GB2425654B (en) * 2005-04-29 2010-03-17 Seiko Epson Corp A method of fabricating a heterojunction of organic semiconducting polymers
EP1722466A1 (en) * 2005-05-13 2006-11-15 STMicroelectronics S.r.l. Method and relative circuit for generating a control voltage of a synchronous rectifier
US7544563B2 (en) * 2005-05-18 2009-06-09 Micron Technology, Inc. Methods of forming a plurality of capacitors
US7517753B2 (en) * 2005-05-18 2009-04-14 Micron Technology, Inc. Methods of forming pluralities of capacitors
TW200716159A (en) * 2005-06-09 2007-05-01 Univ Maryland Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
US7282401B2 (en) 2005-07-08 2007-10-16 Micron Technology, Inc. Method and apparatus for a self-aligned recessed access device (RAD) transistor gate
US7199005B2 (en) * 2005-08-02 2007-04-03 Micron Technology, Inc. Methods of forming pluralities of capacitors
US7867851B2 (en) 2005-08-30 2011-01-11 Micron Technology, Inc. Methods of forming field effect transistors on substrates
US7700441B2 (en) 2006-02-02 2010-04-20 Micron Technology, Inc. Methods of forming field effect transistors, methods of forming field effect transistor gates, methods of forming integrated circuitry comprising a transistor gate array and circuitry peripheral to the gate array, and methods of forming integrated circuitry comprising a transistor gate array including first gates and second grounded isolation gates
BRPI0707616A2 (pt) 2006-02-09 2011-05-10 Alba Therapuetics Corp formulaÇÕes para um efetor de junÇço oclusiva
US7557013B2 (en) 2006-04-10 2009-07-07 Micron Technology, Inc. Methods of forming a plurality of capacitors
US7602001B2 (en) 2006-07-17 2009-10-13 Micron Technology, Inc. Capacitorless one transistor DRAM cell, integrated circuitry comprising an array of capacitorless one transistor DRAM cells, and method of forming lines of capacitorless one transistor DRAM cells
US7772632B2 (en) 2006-08-21 2010-08-10 Micron Technology, Inc. Memory arrays and methods of fabricating memory arrays
US7589995B2 (en) 2006-09-07 2009-09-15 Micron Technology, Inc. One-transistor memory cell with bias gate
US20090069247A1 (en) * 2006-10-06 2009-03-12 Blake Paterson Use of tight junction antagonists to treat inflammatory bowel disease
US7902081B2 (en) 2006-10-11 2011-03-08 Micron Technology, Inc. Methods of etching polysilicon and methods of forming pluralities of capacitors
US8034776B2 (en) * 2006-10-26 2011-10-11 Alba Therapeutics Corporation Materials and methods for the treatment of celiac disease
EP2091551B1 (en) 2006-11-03 2020-01-15 Alba Therapeutics Corporation Method of treating asthma
US7785962B2 (en) 2007-02-26 2010-08-31 Micron Technology, Inc. Methods of forming a plurality of capacitors
US8728491B2 (en) * 2007-05-07 2014-05-20 Alba Therapeutics Corporation Transcutaneous delivery of therapeutic agents
WO2008150981A2 (en) * 2007-05-30 2008-12-11 Alba Therapeutics Corporation Novel short peptides that inhibit the opening of mammalian tight junctions
US7923373B2 (en) 2007-06-04 2011-04-12 Micron Technology, Inc. Pitch multiplication using self-assembling materials
WO2008154493A2 (en) * 2007-06-07 2008-12-18 Alba Therapeutics Corporation Novel peptides that inhibit the opening of mammalian tight junctions
WO2008154350A2 (en) * 2007-06-08 2008-12-18 Alba Therapeutics Corporation Use of tight junction agonists to suppress immune responses
WO2009006246A1 (en) * 2007-06-29 2009-01-08 Alea Therapeutics Corp. Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
WO2009015382A2 (en) 2007-07-26 2009-01-29 Alba Therapeutics Corporation Novel peptides that enhance tight junction permeability
US7682924B2 (en) 2007-08-13 2010-03-23 Micron Technology, Inc. Methods of forming a plurality of capacitors
WO2009052489A2 (en) * 2007-10-19 2009-04-23 Alba Therapeutics Corporation Novel inhibitors of mammalian tight junction opening
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US9051349B2 (en) 2007-11-21 2015-06-09 Alba Therapeutics Corporation Larazotide acetate compositions
WO2009110947A2 (en) * 2007-12-19 2009-09-11 Alba Therapeutics Corporation Compositions and methods for inhibiting cytokine production
US8388851B2 (en) 2008-01-08 2013-03-05 Micron Technology, Inc. Capacitor forming methods
US8274777B2 (en) 2008-04-08 2012-09-25 Micron Technology, Inc. High aspect ratio openings
US8957032B2 (en) * 2008-05-06 2015-02-17 Alba Therapeutics Corporation Inhibition of gliadin peptides
US7759193B2 (en) 2008-07-09 2010-07-20 Micron Technology, Inc. Methods of forming a plurality of capacitors
CN102481362A (zh) * 2009-06-10 2012-05-30 马里兰巴尔的摩大学 表皮生长因子受体(egfr)与蛋白酶活化受体2(par2)对肠道通透性的调节
RU2410765C1 (ru) * 2009-07-21 2011-01-27 Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию Способ профилактики токсического действия никеля у экспериментальных животных при хроническом отравлении
RU2412489C1 (ru) * 2009-09-01 2011-02-20 Государственное образовательное учреждение высшего профессионального образования "Северо-Осетинская государственная медицинская академия" Федерального агентства по здравоохранению и социальному развитию Способ профилактики хронической токсической кардиопатии у экспериментальных животных
US8518788B2 (en) 2010-08-11 2013-08-27 Micron Technology, Inc. Methods of forming a plurality of capacitors
US9076680B2 (en) 2011-10-18 2015-07-07 Micron Technology, Inc. Integrated circuitry, methods of forming capacitors, and methods of forming integrated circuitry comprising an array of capacitors and circuitry peripheral to the array
US8946043B2 (en) 2011-12-21 2015-02-03 Micron Technology, Inc. Methods of forming capacitors
SI3677252T1 (sl) 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov
US8652926B1 (en) 2012-07-26 2014-02-18 Micron Technology, Inc. Methods of forming capacitors
WO2015069718A2 (en) 2013-11-05 2015-05-14 Bio-Rad Laboratories, Inc. Pre-haptoglobin-2 monoclonal antibodies and uses thereof
WO2015154010A1 (en) * 2014-04-04 2015-10-08 Perrow Wendy Methods of treating celiac disease with larazotide
KR20190121785A (ko) 2017-02-10 2019-10-28 이노베이트 바이오파마슈티컬스, 인코포레이티드 장 상피의 투과성과 관련된 질환을 치료하기 위한 조성물 및 방법
WO2019165346A1 (en) 2018-02-23 2019-08-29 Innovate Biopharmaceuticals, Inc. Compounds and methods for treating tight junction permeability
CN117597137A (zh) 2021-04-19 2024-02-23 伊布里斯有限责任公司 用于治疗儿童(mis-c)和成人(mis-a)多系统炎症综合征的连蛋白拮抗剂
CN118873629B (zh) * 2024-09-27 2024-12-10 北京大学口腔医学院 醋酸拉唑肽在制备促进成骨药物中的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US667048A (en) * 1900-07-06 1901-01-29 Edson F Whitman Torpedo-projectile.
US2419898A (en) 1943-12-10 1947-04-29 Int Harvester Co Shelled corn saver for husking devices
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
WO1994011505A1 (en) * 1992-11-10 1994-05-26 Washington University Pars planitis specific polypeptides
AU5615594A (en) * 1992-11-13 1994-06-08 Cancer Research Fund Of Contra Costa Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods
EP0674710B1 (en) * 1992-11-16 2003-05-02 Cancer Research Fund Of Contra Costa Peptides with broad neoplastic specificity
JP2996864B2 (ja) * 1994-03-30 2000-01-11 寳酒造株式会社 抗体可変領域dna
US5665389A (en) 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes
EP0914335A2 (en) * 1996-03-15 1999-05-12 Corixa Corporation Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
US5912323A (en) * 1997-02-20 1999-06-15 University Of Maryland, Baltimore Zonula occludens toxin receptors
US5945510A (en) * 1997-05-21 1999-08-31 University Of Maryland, Baltimore Substantially pure zonulin, a physiological modulator of mammalian tight junctions
US6506577B1 (en) * 1998-03-19 2003-01-14 The Regents Of The University Of California Synthesis and crosslinking of catechol containing copolypeptides
US6458925B1 (en) * 1998-08-03 2002-10-01 University Of Maryland, Baltimore Peptide antagonists of zonulin and methods for use of the same
RU2214271C2 (ru) * 1998-09-14 2003-10-20 Юниверсити Оф Мэриленд, Балтимор Способ применения zot или зонулина для ингибирования антиген-специфической пролиферации лимфоцитов
JP2003534287A (ja) * 2000-05-19 2003-11-18 ユニバーシティ・オブ・メリーランド, ボルティモア 糖尿病発症を予防または遅延させるためのゾヌリンのペプチドアンタゴニストの使用方法
US8034776B2 (en) * 2006-10-26 2011-10-11 Alba Therapeutics Corporation Materials and methods for the treatment of celiac disease

Similar Documents

Publication Publication Date Title
JP2002524393A5 (enExample)
CA2338005A1 (en) Peptide antagonists of zonulin and methods for use of the same
Robert et al. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying
RU2001106615A (ru) Пептидные антагонисты зонулина и способы их применения
EP0938496B1 (en) Heptapeptide oxytocin analogues
TWI221845B (en) Peptide analogues
JP2002523518A5 (enExample)
JP2006519762A5 (enExample)
SE9800550D0 (sv) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
JPH06293659A (ja) 環式付着阻害剤
JP2003507364A5 (enExample)
JP2003534287A5 (enExample)
WO1999060013A3 (en) Il-6 antagonist peptides
WO1998052415B1 (en) Substantially pure zonulin, a physiological modulator of mammalian tight junctions
JP2002524529A5 (enExample)
JP2002512976A5 (enExample)
WO2002005748A3 (en) Medicinal uses of mu-opioid receptor agonists
Kumar et al. Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer.
JP2002525081A5 (enExample)
Chang et al. Luteinizing releasing hormone, synthesis and ARG8-analogs, and conformation-sequence-activity relationships
US5750646A (en) Bradykinin analogs with non-peptide bond
EP0779889A4 (en) PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE
CN102160890B (zh) 包含止痛肽的药物组合物
JP2002513801A5 (enExample)
CN106061494A (zh) 可用于治疗阿片样物质诱导的功能障碍的鸟苷酸环化酶的激动剂